Rheumatoid factor (RF) was firstly included as one of the diagnostic criteria in the 1940s [3]; then anticyclic citrullinated peptide antibody (ACPA) was discovered as an accurate diagnostic and prognostic index for RA with a higher specificity but lower sensitivity. Here, PRTN3 is linked to rheumatoid arthritis.